panel overview
In early trading on Monday, the A-share market bottomed out after a low opening, and the three major indexes fell by more than 1%. On the disk, aerospace, pharmaceutical commerce, chemical pharmacy, medical devices, traditional Chinese medicine, shipbuilding, securities and other sectors rose against the market; Wine making, airports, energy metals, tourism hotels, mining, wind power, semiconductors, environmental protection, batteries and other sectors led the decline. In terms of subject stocks, covid-19 drugs, covid-19 detection, in vitro detection, recombinant protein, heparin concept, Helicobacter pylori, influenza, gene sequencing, monoclonal antibody concept, etc. led the increase; Concepts such as lidar, Sino Russian trade, beer concept, online travel, Saline Lake lithium extraction, power battery, silicon carbide, pumped storage and Baijiu and other concepts led to a fall.
message surface
central bank heavy data released
The credit supply in February was less than expected
Market participants expect that due to the lower than expected data of social finance and new credit, the financing demand of the real economy is weak, and the market expectation of the people’s Bank of China’s further reduction of reserve requirements and interest rates has increased. At present, China’s demand recovery is weak, the pressure on the economy is still large, and the possibility of the people’s Bank of China using interest rate instruments and deposit reserve instruments appropriately increases.
US announces cancellation of MFN treatment for Russia
On March 11 local time, US President Joe Biden delivered a speech at the White House and announced new sanctions against Russia, focusing on the cancellation of permanent normal trade relations (PNTR) treatment for Russia, namely “most favoured nation treatment”, together with the group of seven and EU members. In addition to the sanctions already imposed on Russia, the United States will also increase tariffs on imports from Russia. The bill is expected to vote in both houses of Congress as early as next week.
the State Food and Drug Administration re approved covid-19 antigen detection boxes of many companies to be listed
According to the website of the State Food and drug administration, on the 13th, the State Food and Drug Administration approved the registration application of five covid-19 antigen detection kit products. These five enterprises include Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) , Beijing Hotgen Biotech Co.Ltd(688068) , Tianjin BIOSIS Biotechnology Co., Ltd., Chongqing Mingdao jietest Biotechnology Co., Ltd. and Beijing Lepu Diagnostic Technology Co., Ltd.
Jufeng viewpoint
pre market judgment: weekend news is not optimistic. On the one hand, China’s epidemic data is rising rapidly and the social finance data in February is lower than expected; On the other hand, U.S. stocks corrected again on Friday; The situation in Russia and Ukraine has not yet eased, and the situation in the Middle East has experienced twists and turns. It is expected that the Shanghai stock index will bottom in the range of 3150 ~ 3350. At present, the market is more emotional. It is suggested that investors control their positions and pay attention to risks for stocks with medium and high callback of two financial targets reaching 30%.
In fact, on March 14, the three major indexes collectively opened low, with the Shanghai index falling 1.14%, the Shenzhen composite index falling 1.06% and the gem index falling 1.01%. On the disk, covid-19 detection, health care, commercial chain and other sectors led the rise, while hotel catering, tourism, coal and other sectors led the decline.
After the opening, the stock index continued to shake and build a bottom after a slight rebound. The sectors such as wine making, airport, energy metals, mining, wind power, semiconductor and lithium battery fell sharply, and there was an influx of risk averse funds in the sectors such as medicine, medical treatment, military industry and securities. Recently, we have repeatedly stressed that we should follow the trend and reduce our positions in time with the help of intraday rebound. At present, the wide range of market shock is an opportunity to sell high and absorb low. Reverse operation should be avoided by all means.
investment suggestions: Jufeng investment adviser believes that the central bank has continuously cut reserve requirements and interest rates since December last year to release liquidity, indicating that the policy bottom has appeared; However, the construction of the market bottom is more complex and there is a time lag between the market bottom and the policy bottom, so the trend of A-Shares has twists and turns. After the Spring Festival, value and growth rose one after another. At the end of February, the oversold rebound market fell behind and continued to find the bottom. At present, the construction of A-share bottom box is a good opportunity to sell high and absorb low. Especially when there is intermediate adjustment in the market, but there is no liquidity risk, it is suitable to reduce positions; The medium-term proposal takes growth as the main line, and individual stocks with higher than expected growth in the annual report and the first quarter report can continue to participate in the rebound.
